Metabolic tumour volume of anal carcinoma on (18)FDG PET/CT before combined radiochemotherapy is the only independant determinant of recurrence free survival

Siamak Mohammadkhani Shali, Vanessa Schmitt, Florian F. Behrendt, Oliver H. Winz, Alexander Heinzel, Felix M. Mottaghy, Michael J. Eble, Frederik A. Verburg

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)1390-1394
JournalEuropean Journal of Radiology
Volume85
Issue number8
DOIs
Publication statusPublished - Aug 2016

Keywords

  • Anal carcinoma
  • FDG PET/CT
  • Rad iochemotherapy
  • Radiation therapy planning
  • Prognosis

Cite this